Describing pharmacists' perspectives on current practices and barriers to outpatient glucagon use in people with diabetes
Open Access
- 1 October 2026
- journal article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 67 (1) , 103536
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Glucagon prescribing and prevention of hospitalization for hypoglycemia in a large health systemDiabetes Research and Clinical Practice, 2023
- Impact of pharmacist outreach on glucagon prescribingJournal of the American Pharmacists Association, 2022
- Glucagon: Its evolving role in the management of hypoglycemiaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021
- Glucagon use by U.S. adults with type 1 and type 2 diabetesJournal of Diabetes and its Complications, 2021
- The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviewsPrimary Care Diabetes, 2020
- Impact of pharmacist intervention on glucagon prescribing patterns in an outpatient internal medicine teaching clinicJournal of the American Pharmacists Association, 2020
- Novel Preparations of Glucagon for the Prevention and Treatment of HypoglycemiaCurrent Diabetes Reports, 2019
- Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue SituationDiabetes Technology & Therapeutics, 2019
- The prescription rates of glucagon for hypoglycemia by pediatricians and physicians are low in JapanEndocrine, 2018
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008